This inventor holds 3 USPTO granted patents, plus 1 CIPO patent. Top assignee: Farmarc Nederland Bv. Active years: 1997-1998.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Monument Park, ZA (1997)
- Pretoria, ZA (1997 - 1998)
Company Filing History:
Years Active: 1997-1998
Title: Michiel Coenraad Van Oudtshoorn: Innovator in Pharmaceutical Compositions
Introduction
Michiel Coenraad Van Oudtshoorn is a notable inventor based in Pretoria, South Africa. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compositions that enhance drug stability and efficacy. With a total of 3 patents to his name, Van Oudtshoorn's work is recognized for its practical applications in medicine.
Latest Patents
His latest patents include a pharmaceutical composition that comprises diclofenac and cyclodextrin. This invention outlines a method of preparing an injectable pharmaceutical or veterinary composition that includes either diclofenac or a salt thereof and 2-hydroxypropyl beta-cyclodextrin. The process involves dissolving the active ingredients in water that has been acidified to a pH between 6.0 and 8.5, without the use of a phosphate buffer. The resulting composition demonstrates good stability during storage, making it a valuable addition to pharmaceutical formulations.
Career Highlights
Throughout his career, Van Oudtshoorn has worked with various companies, including Farmarc Nederland Bv and South African Druggists Limited. His experience in these organizations has contributed to his expertise in pharmaceutical development and innovation.
Collaborations
Some of his notable coworkers include Lawrence John Penkler and Lueta Ann Glintenkamp. Their collaborative efforts have likely played a role in advancing the projects they have worked on together.
Conclusion
Michiel Coenraad Van Oudtshoorn stands out as an influential figure in the pharmaceutical industry, with a focus on improving drug formulations. His innovative patents and collaborative spirit continue to impact the field positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile